Advanced Medical Solutions reaffirms dividend, but sees ongoing pandemic-led hit to sales

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Wound care company Advanced Medical Solutions reaffirmed its dividend even as the Covid-19 impact was denting revenue by as much as 5% a month.

As a result of the pandemic hit to operations, the company 'has been experiencing reductions to its revenues at the upper end of the 3% to 5% of annual sales per month estimate announced by the board in April,' the company said.

The company said the impact of the pandemic would continue, albeit at a lower level, in the second half of the year

Despite expectations for a gradual return to more normalised levels of hospital activity for both its surgical and woundcare businesses, the company said it expected the effects of Covid-19 'will continue to have an impact in the second half of 2020, albeit at a lower level, as volumes will take time to recover to pre-COVID-19 levels.'

The company reconfirmed its intention to recommend the payment of the proposed final dividend for 2019.

At 8:04am: (LON:AMS) Advanced Medical Solutions Group PLC share price was -1p at 251.5p